Asia-Pacific Neurological Biomarkers Market Report 2018
This report studies the Neurological Biomarkers Market status and outlook of Asia-Pacific and major countries, from angles of players, regions, product types and end industries; this report analyzes the top players in Asia-Pacific and major countries, and splits the Neurological Biomarkers Market by product type and applications/end industries.
In the last several years, Asia Pacific market of Neurological Biomarkers developed rapidly, with an average growth rate of 21.4%. In 2017, Asia Pacific revenue of Neurological Biomarkers is nearly 360 M USD.
The major players in Asia Pacific Neurological Biomarkers market include
In the last several years, Asia Pacific market of Neurological Biomarkers developed rapidly, with an average growth rate of 21.4%. In 2017, Asia Pacific revenue of Neurological Biomarkers is nearly 360 M USD.
The major players in Asia Pacific Neurological Biomarkers market include
- Thermo Fisher
- Merck
- Bio-Rad Laboratories
- Roche
- QIAGEN
- Athena Diagnostics
- Myriad RBM
- Cisbio Bioassays
- Wuxi APP
- BGI
- Aepodia
- Genewiz
- Proteome Sciences
- Japan
- China
- India
- Korea
- Southeast Asia
- Australia
- RoAP
- Proteomics
- Genomics
- Imaging
- Bioinformatics
- Others
- Diagnostics
- Drug Discovery
- Personalized Medicine
- Others
1 NEUROLOGICAL BIOMARKERS OVERVIEW
1.1 Product Overview and Scope of Neurological Biomarkers
1.2 Classification of Neurological Biomarkers by Product Category
1.2.1 Asia-Pacific Neurological Biomarkers Revenue Comparison by Types (2013-2024)
1.2.2 Asia-Pacific Neurological Biomarkers Revenue Market Share by Types in 2017
1.2.3 Genomics
1.2.4 Proteomics
1.2.5 Imaging
1.2.6 Bioinformatics
1.3 Asia-Pacific Neurological Biomarkers Market by Applications/End Users
1.3.1 Asia-Pacific Neurological Biomarkers Revenue and Market Share Comparison by Applications (2013-2024)
1.3.2 Drug Discovery
1.3.3 Diagnostics
1.3.4 Personalized Medicine
1.4 Asia-Pacific Neurological Biomarkers Market by Regions
1.4.1 Asia-Pacific Neurological Biomarkers Revenue Comparison by Regions (2013-2024)
1.4.2 China Neurological Biomarkers Status and Prospect (2013-2024)
1.4.3 Japan Neurological Biomarkers Status and Prospect (2013-2024)
1.4.4 Korea Neurological Biomarkers Status and Prospect (2013-2024)
1.4.5 India Neurological Biomarkers Status and Prospect (2013-2024)
1.4.6 Southeast Asia Neurological Biomarkers Status and Prospect (2013-2024)
1.4.7 Australia Neurological Biomarkers Status and Prospect (2013-2024)
1.4.8 RoAP Neurological Biomarkers Status and Prospect (2013-2024)
1.5 Asia-Pacific Revenue and Revenue of Neurological Biomarkers (2013-2024)
2 ASIA-PACIFIC NEUROLOGICAL BIOMARKERS COMPETITION BY PLAYERS/MANUFACTURERS, TYPE AND APPLICATION
2.1 Asia-Pacific Neurological Biomarkers Market Competition by Players/Manufacturers
2.2 Asia-Pacific Neurological Biomarkers Revenue and Revenue by Type
2.3 Asia-Pacific Neurological Biomarkers Revenue and Revenue by Regions
2.4 Asia-Pacific Neurological Biomarkers Revenue by Application
3 CHINA NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
3.1 China Neurological Biomarkers Revenue and Market Share (2013-2018)
3.2 China Neurological Biomarkers Revenue and Market Share by Type
3.3 China Neurological Biomarkers Revenue and Market Share by Applications
4 JAPAN NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
4.1 Japan Neurological Biomarkers Revenue and Market Share (2013-2018)
4.2 Japan Neurological Biomarkers Revenue and Market Share by Type
4.3 Japan Neurological Biomarkers Revenue and Market Share by Applications
5 KOREA NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
5.1 Korea Neurological Biomarkers Revenue and Market Share (2013-2018)
5.2 Korea Neurological Biomarkers Revenue and Market Share by Type
5.3 Korea Neurological Biomarkers Revenue and Market Share by Applications
6 INDIA NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
6.1 India Neurological Biomarkers Revenue and Market Share (2013-2018)
6.2 India Neurological Biomarkers Revenue and Market Share by Type
6.3 India Neurological Biomarkers Revenue and Market Share by Applications
7 AUSTRALIA NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
7.1 Australia Neurological Biomarkers Revenue and Market Share (2013-2018)
7.2 Australia Neurological Biomarkers Revenue and Market Share by Type
7.3 Australia Neurological Biomarkers Revenue and Market Share by Applications
8 SOUTHEAST ASIA NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
8.1 Southeast Asia Neurological Biomarkers Revenue and Market Share (2013-2018)
8.2 Southeast Asia Neurological Biomarkers Revenue and Market Share by Type
8.3 Southeast Asia Neurological Biomarkers Revenue and Market Share by Applications
9 ROAP NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
9.1 RoAP Neurological Biomarkers Revenue and Market Share (2013-2018)
9.2 RoAP Neurological Biomarkers Revenue and Market Share by Type
9.3 RoAP Neurological Biomarkers Revenue and Market Share by Applications
10 ANALYSIS OF NEUROLOGICAL BIOMARKERS INDUSTRY KEY MANUFACTURERS
10.1 Thermo Fisher
10.1.1 Company Profile
10.1.2 Product Information
10.1.3 Revenue, Cost, Gross and Gross Margin
10.2 Merck
10.2.1 Company Profile
10.2.2 Product Information
10.2.3 Revenue, Cost, Gross and Gross Margin
10.3 Bio-Rad Laboratories
10.3.1 Company Profile
10.3.2 Product Information
10.3.3 Revenue, Cost, Gross and Gross Margin
10.4 Roche
10.4.1 Company Profile
10.4.2 Product Information
10.4.3 Revenue, Cost, Gross and Gross Margin
10.5 QIAGEN
10.5.1 Company Profile
10.5.2 Product Information
10.5.3 Revenue, Cost, Gross and Gross Margin
10.6 Athena Diagnostics
10.6.1 Company Profile
10.6.2 Product Information
10.6.3 Revenue, Cost, Gross and Gross Margin
10.7 Myriad RBM
10.7.1 Company Profile
10.7.2 Product Information
10.7.3 Revenue, Cost, Gross and Gross Margin
10.8 Cisbio Bioassays
10.8.1 Company Profile
10.8.2 Product Information
10.8.3 Revenue, Cost, Gross and Gross Margin
10.9 Wuxi APP
10.9.1 Company Profile
10.9.2 Product Information
10.9.3 Revenue, Cost, Gross and Gross Margin
10.10 BGI
10.10.1 Company Profile
10.10.2 Product Information
10.10.3 Revenue, Cost, Gross and Gross Margin
10.11 Aepodia
10.11.1 Company Profile
10.11.2 Product Information
10.11.3 Revenue, Cost, Gross and Gross Margin
10.12 Genewiz
10.12.1 Company Profile
10.12.2 Product Information
10.12.3 Revenue, Cost, Gross and Gross Margin
10.13 Proteome Sciences
10.13.1 Company Profile
10.13.2 Product Information
10.13.3 Revenue, Cost, Gross and Gross Margin
11 NEUROLOGICAL BIOMARKERS AS COST ANALYSIS
11.1 Drug Development R&D Cost Analysis
11.1.1 Clinical Phase Costs
11.1.2 Capitalized Costs
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.2.1 USA Labor Cost Analysis
11.2.2.2 Europe Labor Costs Analysis
11.2.2.3 Asia Labor Costs Analysis
11.2.3 Other Costs Analysis
11.2.3.1 USA Other Cost Analysis
11.2.3.2 Europe Other Cost Analysis
11.2.3.3 China Other Cost Analysis
11.3 Manufacturing Process Analysis of Neurological Biomarkers
12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
12.1 Neurological Biomarkers Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Downstream Buyers
13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Market Positioning
13.2.2 Brand Strategy
13.2.2.1 Introducing pharmaceutical branding strategies
13.2.2.2 Building pharmaceutical brands
13.2.2.3 Communicating pharmaceutical brands
13.2.2.4 Alternative brand models
13.2.2.5 The future of pharmaceutical branding
13.3 Distributors/Traders List
14 MARKET EFFECT FACTORS ANALYSIS
14.1 Technology Progress/Risk
14.1.1 Biomarker Development Pipeline
14.1.2 Technologies Progress of Biomarker
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change
15 ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET FORECAST (2018-2024)
15.1 Asia-Pacific Neurological Biomarkers Revenue Forecast (2018-2024)
15.2 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate Forecast by Regions (2018-2024)
15.2.1 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate Forecast by Regions (2018-2024)
15.2.2 China Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.2.3 Korea Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.2.4 Japan Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.2.5 India Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.2.6 Southeast Asia Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.2.7 Australia Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.2.8 RoAP Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.3 Asia-Pacific Neurological Biomarkers Revenue and Price Forecast by Type (2018-2024)
15.4 Asia-Pacific Neurological Biomarkers Revenue Forecast by Application (2018-2024)
16 RESEARCH FINDINGS AND CONCLUSION
17 METHODOLOGY AND DATA SOURCE
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer
17.4 Author List
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1.1 Product Overview and Scope of Neurological Biomarkers
1.2 Classification of Neurological Biomarkers by Product Category
1.2.1 Asia-Pacific Neurological Biomarkers Revenue Comparison by Types (2013-2024)
1.2.2 Asia-Pacific Neurological Biomarkers Revenue Market Share by Types in 2017
1.2.3 Genomics
1.2.4 Proteomics
1.2.5 Imaging
1.2.6 Bioinformatics
1.3 Asia-Pacific Neurological Biomarkers Market by Applications/End Users
1.3.1 Asia-Pacific Neurological Biomarkers Revenue and Market Share Comparison by Applications (2013-2024)
1.3.2 Drug Discovery
1.3.3 Diagnostics
1.3.4 Personalized Medicine
1.4 Asia-Pacific Neurological Biomarkers Market by Regions
1.4.1 Asia-Pacific Neurological Biomarkers Revenue Comparison by Regions (2013-2024)
1.4.2 China Neurological Biomarkers Status and Prospect (2013-2024)
1.4.3 Japan Neurological Biomarkers Status and Prospect (2013-2024)
1.4.4 Korea Neurological Biomarkers Status and Prospect (2013-2024)
1.4.5 India Neurological Biomarkers Status and Prospect (2013-2024)
1.4.6 Southeast Asia Neurological Biomarkers Status and Prospect (2013-2024)
1.4.7 Australia Neurological Biomarkers Status and Prospect (2013-2024)
1.4.8 RoAP Neurological Biomarkers Status and Prospect (2013-2024)
1.5 Asia-Pacific Revenue and Revenue of Neurological Biomarkers (2013-2024)
2 ASIA-PACIFIC NEUROLOGICAL BIOMARKERS COMPETITION BY PLAYERS/MANUFACTURERS, TYPE AND APPLICATION
2.1 Asia-Pacific Neurological Biomarkers Market Competition by Players/Manufacturers
2.2 Asia-Pacific Neurological Biomarkers Revenue and Revenue by Type
2.3 Asia-Pacific Neurological Biomarkers Revenue and Revenue by Regions
2.4 Asia-Pacific Neurological Biomarkers Revenue by Application
3 CHINA NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
3.1 China Neurological Biomarkers Revenue and Market Share (2013-2018)
3.2 China Neurological Biomarkers Revenue and Market Share by Type
3.3 China Neurological Biomarkers Revenue and Market Share by Applications
4 JAPAN NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
4.1 Japan Neurological Biomarkers Revenue and Market Share (2013-2018)
4.2 Japan Neurological Biomarkers Revenue and Market Share by Type
4.3 Japan Neurological Biomarkers Revenue and Market Share by Applications
5 KOREA NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
5.1 Korea Neurological Biomarkers Revenue and Market Share (2013-2018)
5.2 Korea Neurological Biomarkers Revenue and Market Share by Type
5.3 Korea Neurological Biomarkers Revenue and Market Share by Applications
6 INDIA NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
6.1 India Neurological Biomarkers Revenue and Market Share (2013-2018)
6.2 India Neurological Biomarkers Revenue and Market Share by Type
6.3 India Neurological Biomarkers Revenue and Market Share by Applications
7 AUSTRALIA NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
7.1 Australia Neurological Biomarkers Revenue and Market Share (2013-2018)
7.2 Australia Neurological Biomarkers Revenue and Market Share by Type
7.3 Australia Neurological Biomarkers Revenue and Market Share by Applications
8 SOUTHEAST ASIA NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
8.1 Southeast Asia Neurological Biomarkers Revenue and Market Share (2013-2018)
8.2 Southeast Asia Neurological Biomarkers Revenue and Market Share by Type
8.3 Southeast Asia Neurological Biomarkers Revenue and Market Share by Applications
9 ROAP NEUROLOGICAL BIOMARKERS REVENUE ANALYSIS
9.1 RoAP Neurological Biomarkers Revenue and Market Share (2013-2018)
9.2 RoAP Neurological Biomarkers Revenue and Market Share by Type
9.3 RoAP Neurological Biomarkers Revenue and Market Share by Applications
10 ANALYSIS OF NEUROLOGICAL BIOMARKERS INDUSTRY KEY MANUFACTURERS
10.1 Thermo Fisher
10.1.1 Company Profile
10.1.2 Product Information
10.1.3 Revenue, Cost, Gross and Gross Margin
10.2 Merck
10.2.1 Company Profile
10.2.2 Product Information
10.2.3 Revenue, Cost, Gross and Gross Margin
10.3 Bio-Rad Laboratories
10.3.1 Company Profile
10.3.2 Product Information
10.3.3 Revenue, Cost, Gross and Gross Margin
10.4 Roche
10.4.1 Company Profile
10.4.2 Product Information
10.4.3 Revenue, Cost, Gross and Gross Margin
10.5 QIAGEN
10.5.1 Company Profile
10.5.2 Product Information
10.5.3 Revenue, Cost, Gross and Gross Margin
10.6 Athena Diagnostics
10.6.1 Company Profile
10.6.2 Product Information
10.6.3 Revenue, Cost, Gross and Gross Margin
10.7 Myriad RBM
10.7.1 Company Profile
10.7.2 Product Information
10.7.3 Revenue, Cost, Gross and Gross Margin
10.8 Cisbio Bioassays
10.8.1 Company Profile
10.8.2 Product Information
10.8.3 Revenue, Cost, Gross and Gross Margin
10.9 Wuxi APP
10.9.1 Company Profile
10.9.2 Product Information
10.9.3 Revenue, Cost, Gross and Gross Margin
10.10 BGI
10.10.1 Company Profile
10.10.2 Product Information
10.10.3 Revenue, Cost, Gross and Gross Margin
10.11 Aepodia
10.11.1 Company Profile
10.11.2 Product Information
10.11.3 Revenue, Cost, Gross and Gross Margin
10.12 Genewiz
10.12.1 Company Profile
10.12.2 Product Information
10.12.3 Revenue, Cost, Gross and Gross Margin
10.13 Proteome Sciences
10.13.1 Company Profile
10.13.2 Product Information
10.13.3 Revenue, Cost, Gross and Gross Margin
11 NEUROLOGICAL BIOMARKERS AS COST ANALYSIS
11.1 Drug Development R&D Cost Analysis
11.1.1 Clinical Phase Costs
11.1.2 Capitalized Costs
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.2.1 USA Labor Cost Analysis
11.2.2.2 Europe Labor Costs Analysis
11.2.2.3 Asia Labor Costs Analysis
11.2.3 Other Costs Analysis
11.2.3.1 USA Other Cost Analysis
11.2.3.2 Europe Other Cost Analysis
11.2.3.3 China Other Cost Analysis
11.3 Manufacturing Process Analysis of Neurological Biomarkers
12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
12.1 Neurological Biomarkers Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Downstream Buyers
13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Market Positioning
13.2.2 Brand Strategy
13.2.2.1 Introducing pharmaceutical branding strategies
13.2.2.2 Building pharmaceutical brands
13.2.2.3 Communicating pharmaceutical brands
13.2.2.4 Alternative brand models
13.2.2.5 The future of pharmaceutical branding
13.3 Distributors/Traders List
14 MARKET EFFECT FACTORS ANALYSIS
14.1 Technology Progress/Risk
14.1.1 Biomarker Development Pipeline
14.1.2 Technologies Progress of Biomarker
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change
15 ASIA-PACIFIC NEUROLOGICAL BIOMARKERS MARKET FORECAST (2018-2024)
15.1 Asia-Pacific Neurological Biomarkers Revenue Forecast (2018-2024)
15.2 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate Forecast by Regions (2018-2024)
15.2.1 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate Forecast by Regions (2018-2024)
15.2.2 China Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.2.3 Korea Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.2.4 Japan Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.2.5 India Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.2.6 Southeast Asia Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.2.7 Australia Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.2.8 RoAP Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)
15.3 Asia-Pacific Neurological Biomarkers Revenue and Price Forecast by Type (2018-2024)
15.4 Asia-Pacific Neurological Biomarkers Revenue Forecast by Application (2018-2024)
16 RESEARCH FINDINGS AND CONCLUSION
17 METHODOLOGY AND DATA SOURCE
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer
17.4 Author List
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Product Picture of Neurological Biomarkers
Figure Asia-Pacific Neurological Biomarkers Revenue (M USD) and Growth Rate Comparison by Types (2013-2024)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Types in 2017
Figure Genomics Product Picture
Figure Proteomics Product Picture
Figure Imaging Product Picture
Figure Bioinformatics Product Picture
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Comparison by Applications (2013-2024)
Figure Asia-Pacific Revenue Market Share of Neurological Biomarkers by Applications in 2017
Figure Drug Discovery Examples
Figure Diagnostics Examples
Figure Personalized Medicine Examples
Table Asia-Pacific Market Neurological Biomarkers Revenue (M USD) Comparison by Regions 2013-2024
Figure China Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure Japan Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure Korea Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure India Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure Southeast Asia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure Australia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure RoAP Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure Asia-Pacific Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Players/Manufacturers (2016-2017)
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Players/Manufacturers (2016-2017)
Figure 2016 Asia-Pacific Neurological Biomarkers Revenue Market Share by Players/Manufacturers
Figure 2017 Asia-Pacific Neurological Biomarkers Revenue Market Share by Players/Manufacturers
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure Revenue Market Share of Neurological Biomarkers by Type (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue Growth Rate by Type in 2017
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Regions (2013-2018)
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Regions (2013-2018)
Figure Revenue Market Share of Neurological Biomarkers by Regions (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Regions in 2017
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Application (2013-2018)
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Application (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Application (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Application in 2017
Figure China Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table China Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table China Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure China Neurological Biomarkers Revenue Market Share by Type in 2017
Table China Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table China Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure China Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure Japan Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table Japan Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table Japan Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure Japan Neurological Biomarkers Revenue Market Share by Type in 2017
Table Japan Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table Japan Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure Japan Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure Korea Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table Korea Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table Korea Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure Korea Neurological Biomarkers Revenue Market Share by Type in 2017
Table Korea Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table Korea Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure Korea Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure India Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table India Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table India Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure India Neurological Biomarkers Revenue Market Share by Type in 2017
Table India Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table India Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure India Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure Australia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table Australia Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table Australia Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure Australia Neurological Biomarkers Revenue Market Share by Type in 2017
Table Australia Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table Australia Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure Australia Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure Southeast Asia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table Southeast Asia Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table Southeast Asia Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure Southeast Asia Neurological Biomarkers Revenue Market Share by Type in 2017
Table Southeast Asia Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table Southeast Asia Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure Southeast Asia Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure RoAP Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table RoAP Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table RoAP Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure RoAP Neurological Biomarkers Revenue Market Share by Type in 2017
Table RoAP Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table RoAP Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure RoAP Neurological Biomarkers Revenue Market Share by Applications in 2017
Table Thermo Fisher Company Profile
Figure Neurological Biomarkers Product Picture and Specifications of Thermo Fisher
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Thermo Fisher 2016-2017
Table Merck Company Profile
Figure Neurological Biomarkers Product Picture and Specifications of Merck
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Merck 2016-2017
Table Bio-Rad Laboratories Company Profile
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Bio-Rad Laboratories 2016-2017
Table Roche Company Profile
Table Neurological Biomarkers Product Picture and Specifications of Roche
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Roche 2016-2017
Table QIAGEN Company Profile
Table Neurological Biomarkers Product Picture and Specifications of QIAGEN
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of QIAGEN 2016-2017
Table Athena Diagnostics Company Profile
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Athena Diagnostics 2016-2017
Table Myriad RBM Company Profile
Figure Neurological Biomarkers Product Picture and Specifications of Myriad RBM
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Myriad RBM 2016-2017
Table Cisbio Bioassays Company Profile
Figure Neurological Biomarkers Product Picture and Specifications of Cisbio Bioassays
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Cisbio Bioassays 2016-2017
Table Wuxi APP Company Profile
Table Neurological Biomarkers Product Picture and Specifications of Wuxi APP
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Wuxi APP 2016-2017
Table BGI Company Profile
Table Neurological Biomarkers Product Picture and Specifications of BGI
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of BGI 2016-2017
Table Aepodia Company Profile
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Aepodia 2016-2017
Table Genewiz Company Profile
Table Neurological Biomarkers Product Picture and Specifications of Genewiz
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Genewiz 2016-2017
Table Proteome Sciences Company Profile
Table Neurological Biomarkers Product Picture and Specifications of Proteome Sciences
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Proteome Sciences 2016-2017
Figure typical phases from research to the market for a drug candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Manufacturing Cost Structure of Neurological Biomarkers
Figure USA Overview of Average Hourly Wages 2016-2017 (USD/Hour)
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points)
Figure Cost of Employing a Factory Worker
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe
Figure Monthly Minimum Wages in Asia 2016
Figure China Overview of Average Yearly Wages 2016-2017 (CNY/Year)
Figure Japan Overview of Average Monthly Wages 2016-2017 (JPY Thousand/Month)
Table Average Price of Electricity to Ultimate Customers
Figure Electricity Prices for Household Consumers in 2016
Figure Summary of the Driving Assumptions
Figure Industrial Electric Rates 2016 (PER KWH)
Figure Manufacturing Process Analysis of Neurological Biomarkers
Figure Neurological Biomarkers Industrial Chain Analysis
Table Major Buyers of Neurological Biomarkers
Table Distributors/Traders List
Figure Biomarker Development Pipeline
Figure Shotgun Proteomics For Biomarker Candidate Discovery
Figure Spectral Counting
Figure Targeted Quantitative Analyses of Biomarker Candidates
Figure Antibody Development for Biomarker Candidates
Figure Global GDP Growth Rate for 2016
Figure Japan GDP 2006-2016 (Billion USD)
Figure Japan CPI Change 2012-2016
Figure China GDP 2006-2016 (Billion USD)
Figure China CPI Change 2016-2017
Figure Korea GDP 2006-2016 (Billion USD)
Figure Korea CPI Change 2017
Figure India GDP 2006-2016 (Billion USD)
Figure India CPI Change 2017
Figure Australia GDP 2006-2016 (Billion USD)
Figure Australia CPI Change 2015-2017
Figure Taiwan GDP 2006-2016 (Billion USD)
Figure Taiwan CPI Change 2017
Figure Asia-Pacific Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Forecast by Regions (2018-2024)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Regions (2018-2024)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Regions in 2023
Figure China Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Figure Korea Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Figure Japan Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Figure India Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Figure Southeast Asia Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Figure Australia Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Figure RoAP Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Forecast by Type (2018-2024)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Type (2018-2024)
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Forecast by Application (2018-2024)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Application (2018-2024)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Product Picture of Neurological Biomarkers
Figure Asia-Pacific Neurological Biomarkers Revenue (M USD) and Growth Rate Comparison by Types (2013-2024)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Types in 2017
Figure Genomics Product Picture
Figure Proteomics Product Picture
Figure Imaging Product Picture
Figure Bioinformatics Product Picture
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Comparison by Applications (2013-2024)
Figure Asia-Pacific Revenue Market Share of Neurological Biomarkers by Applications in 2017
Figure Drug Discovery Examples
Figure Diagnostics Examples
Figure Personalized Medicine Examples
Table Asia-Pacific Market Neurological Biomarkers Revenue (M USD) Comparison by Regions 2013-2024
Figure China Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure Japan Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure Korea Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure India Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure Southeast Asia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure Australia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure RoAP Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Figure Asia-Pacific Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Players/Manufacturers (2016-2017)
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Players/Manufacturers (2016-2017)
Figure 2016 Asia-Pacific Neurological Biomarkers Revenue Market Share by Players/Manufacturers
Figure 2017 Asia-Pacific Neurological Biomarkers Revenue Market Share by Players/Manufacturers
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure Revenue Market Share of Neurological Biomarkers by Type (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue Growth Rate by Type in 2017
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Regions (2013-2018)
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Regions (2013-2018)
Figure Revenue Market Share of Neurological Biomarkers by Regions (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Regions in 2017
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Application (2013-2018)
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Application (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Application (2013-2018)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Application in 2017
Figure China Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table China Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table China Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure China Neurological Biomarkers Revenue Market Share by Type in 2017
Table China Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table China Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure China Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure Japan Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table Japan Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table Japan Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure Japan Neurological Biomarkers Revenue Market Share by Type in 2017
Table Japan Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table Japan Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure Japan Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure Korea Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table Korea Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table Korea Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure Korea Neurological Biomarkers Revenue Market Share by Type in 2017
Table Korea Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table Korea Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure Korea Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure India Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table India Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table India Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure India Neurological Biomarkers Revenue Market Share by Type in 2017
Table India Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table India Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure India Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure Australia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table Australia Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table Australia Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure Australia Neurological Biomarkers Revenue Market Share by Type in 2017
Table Australia Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table Australia Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure Australia Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure Southeast Asia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table Southeast Asia Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table Southeast Asia Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure Southeast Asia Neurological Biomarkers Revenue Market Share by Type in 2017
Table Southeast Asia Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table Southeast Asia Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure Southeast Asia Neurological Biomarkers Revenue Market Share by Applications in 2017
Figure RoAP Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)
Table RoAP Neurological Biomarkers Revenue (M USD) by Type (2013-2018)
Table RoAP Neurological Biomarkers Revenue Market Share by Type (2013-2018)
Figure RoAP Neurological Biomarkers Revenue Market Share by Type in 2017
Table RoAP Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)
Table RoAP Neurological Biomarkers Revenue Market Share by Applications (2013-2018)
Figure RoAP Neurological Biomarkers Revenue Market Share by Applications in 2017
Table Thermo Fisher Company Profile
Figure Neurological Biomarkers Product Picture and Specifications of Thermo Fisher
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Thermo Fisher 2016-2017
Table Merck Company Profile
Figure Neurological Biomarkers Product Picture and Specifications of Merck
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Merck 2016-2017
Table Bio-Rad Laboratories Company Profile
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Bio-Rad Laboratories 2016-2017
Table Roche Company Profile
Table Neurological Biomarkers Product Picture and Specifications of Roche
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Roche 2016-2017
Table QIAGEN Company Profile
Table Neurological Biomarkers Product Picture and Specifications of QIAGEN
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of QIAGEN 2016-2017
Table Athena Diagnostics Company Profile
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Athena Diagnostics 2016-2017
Table Myriad RBM Company Profile
Figure Neurological Biomarkers Product Picture and Specifications of Myriad RBM
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Myriad RBM 2016-2017
Table Cisbio Bioassays Company Profile
Figure Neurological Biomarkers Product Picture and Specifications of Cisbio Bioassays
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Cisbio Bioassays 2016-2017
Table Wuxi APP Company Profile
Table Neurological Biomarkers Product Picture and Specifications of Wuxi APP
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Wuxi APP 2016-2017
Table BGI Company Profile
Table Neurological Biomarkers Product Picture and Specifications of BGI
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of BGI 2016-2017
Table Aepodia Company Profile
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Aepodia 2016-2017
Table Genewiz Company Profile
Table Neurological Biomarkers Product Picture and Specifications of Genewiz
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Genewiz 2016-2017
Table Proteome Sciences Company Profile
Table Neurological Biomarkers Product Picture and Specifications of Proteome Sciences
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Proteome Sciences 2016-2017
Figure typical phases from research to the market for a drug candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Manufacturing Cost Structure of Neurological Biomarkers
Figure USA Overview of Average Hourly Wages 2016-2017 (USD/Hour)
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points)
Figure Cost of Employing a Factory Worker
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe
Figure Monthly Minimum Wages in Asia 2016
Figure China Overview of Average Yearly Wages 2016-2017 (CNY/Year)
Figure Japan Overview of Average Monthly Wages 2016-2017 (JPY Thousand/Month)
Table Average Price of Electricity to Ultimate Customers
Figure Electricity Prices for Household Consumers in 2016
Figure Summary of the Driving Assumptions
Figure Industrial Electric Rates 2016 (PER KWH)
Figure Manufacturing Process Analysis of Neurological Biomarkers
Figure Neurological Biomarkers Industrial Chain Analysis
Table Major Buyers of Neurological Biomarkers
Table Distributors/Traders List
Figure Biomarker Development Pipeline
Figure Shotgun Proteomics For Biomarker Candidate Discovery
Figure Spectral Counting
Figure Targeted Quantitative Analyses of Biomarker Candidates
Figure Antibody Development for Biomarker Candidates
Figure Global GDP Growth Rate for 2016
Figure Japan GDP 2006-2016 (Billion USD)
Figure Japan CPI Change 2012-2016
Figure China GDP 2006-2016 (Billion USD)
Figure China CPI Change 2016-2017
Figure Korea GDP 2006-2016 (Billion USD)
Figure Korea CPI Change 2017
Figure India GDP 2006-2016 (Billion USD)
Figure India CPI Change 2017
Figure Australia GDP 2006-2016 (Billion USD)
Figure Australia CPI Change 2015-2017
Figure Taiwan GDP 2006-2016 (Billion USD)
Figure Taiwan CPI Change 2017
Figure Asia-Pacific Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Forecast by Regions (2018-2024)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Regions (2018-2024)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Regions in 2023
Figure China Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Figure Korea Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Figure Japan Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Figure India Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Figure Southeast Asia Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Figure Australia Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Figure RoAP Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Forecast by Type (2018-2024)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Type (2018-2024)
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Forecast by Application (2018-2024)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Application (2018-2024)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
